Related Experiment Video
Updated: Jan 14, 2026

08:24
A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation
Published on: May 9, 2012
21.5K
Exercise and myasthenia gravis.
Simone Birnbaum1, Linda Kahr Andersen2
1Neuromuscular Physiology and Evaluation Laboratory, Institute of Myology, Paris, France.
International Review of Neurobiology
|October 16, 2025
Summary
Exercise training is feasible and beneficial for Myasthenia Gravis (MG) patients, improving strength and reducing fatigue. Addressing barriers to physical activity is crucial for managing MG symptoms and enhancing quality of life.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Exercise Science
Background:
- Non-pharmacological management, particularly exercise, is underutilized in Myasthenia Gravis (MG).
- Existing evidence suggests exercise training is feasible and improves function and strength in individuals with MG.
- Physical activity is linked to reduced perceived fatigue in MG patients.
Purpose of the Study:
- To review the existing literature on exercise in Myasthenia Gravis.
- To highlight the benefits of exercise training for individuals with MG.
- To identify barriers to exercise and suggest areas for future research.
Main Methods:
- Literature review of studies on exercise and physical activity in Myasthenia Gravis.
- Analysis of observational data linking physical activity to fatigue reduction.
- Synthesis of current understanding of exercise's role in MG management.
Main Results:
- Exercise training demonstrates feasibility and benefits in improving strength and function in MG.
- Physical activity is associated with decreased perceived fatigue.
- Prioritizing muscle strength, endurance, and cardiorespiratory fitness is recommended for all MG patients.
Conclusions:
- Exercise programs for MG should be individualized, progressive, and focus on reducing sedentary behavior.
- Further research is needed on exercise's impact on pharmacological therapies and immunomodulation in MG.
- Healthcare professionals should address persistent barriers to exercise in MG.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Chemical Synapses
11.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.2K
Chemical Synapses
4.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.3K
Muscle Contraction
8.8K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
8.8K

